ENTITY
Lifang Pharmaceutical
Lifang Pharmaceutical
PulseAugur coverage of Lifang Pharmaceutical — every cluster mentioning Lifang Pharmaceutical across labs, papers, and developer communities, ranked by signal.
Total · 30d
1
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-05-22 product_launch Lifang Pharmaceutical received approval for its Azilsartan Medoxomil Potassium tablets. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Lifang Pharmaceutical subsidiary's eye drop application accepted
Lifang Pharmaceutical's subsidiary, Hefei Norite Pharmaceutical, has received a "Notice of Acceptance" from China's National Medical Products Administration for its polyvinyl alcohol eye drops. These eye drops function …
-
Lifang Pharmaceutical secures approval for hypertension drug
Lifang Pharmaceutical has received approval from China's National Medical Products Administration for its Azilsartan Medoxomil Potassium tablets, indicated for treating adult primary hypertension. This marks a significa…